Gama Paul sold $698K of PG
Gama Paul (CEO- Health Care) sold 4,331 shares of PROCTER & GAMBLE Co (PG) at $161.27 ($0.70M total) on 2026-10-23.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and unlikely to move the stock significantly, but it provides a data point for monitoring insider activity.
Market read
A small insider sale by a senior executive, low immediate market impact.
What to watch
The sale size is tiny relative to PG's market cap and may not reflect company fundamentals.
Background
Form 4 filings disclose insider transactions and are used by traders to gauge potential sentiment shifts.
Ticker impact
CEO Gama Paul sold 4,331 shares of Procter & Gamble for $698,460, reducing his stake to 46,793 shares.
likely modest downward pressure as the market prices the insider sale
A $698k sale by a senior executive is a primary filing but the amount is small relative to market cap, so impact is limited.
Market effects
Minimal effect on consumer staples sector; insider sales are routine.
No regional impact.
Low relevance globally.
Counterpoint
The sale could be interpreted as a routine portfolio rebalancing, not a negative signal.
Key entities
- CompanyProcter & Gamble Co
Consumer goods conglomerate (ticker PG).
- IndividualGama Paul
CEO of Health Care division at Procter & Gamble.
